Combining GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Prevention: Evidence From Randomized Outcomes Trials. [PDF]
Gerstein HC, Sattar N.
europepmc +1 more source
GLP-1 Receptor Agonists Versus Bariatric Surgery: Effects of Weight Loss and BMI on Subsequent General Surgical Procedures. [PDF]
Zindani S +10 more
europepmc +1 more source
The Impact of GLP-1 Receptor Agonists on Esophagogastroduodenoscopy Outcomes: A Retrospective Cohort Study in a Predominantly African American Population. [PDF]
El Sabagh A +13 more
europepmc +1 more source
Distilling the evidence for GLP-1 receptor agonists in alcohol use disorder. [PDF]
Bernstein EY, Schacht JP.
europepmc +1 more source
Reassessing cancer risk with GLP-1 receptor agonists: a comprehensive meta-analysis of gastrointestinal malignancies. [PDF]
Wali AF +5 more
europepmc +1 more source
GLP-1 receptor agonists for weight loss: A systematic review and meta-analysis of randomized controlled trials. [PDF]
Ahmad N +6 more
europepmc +1 more source
GLP-1 receptor agonists for smoking cessation: a narrative review of weight management potential. [PDF]
Ahmed GU +6 more
europepmc +1 more source
Beyond lifestyle modification: the role of GLP-1 receptor agonists in treating pediatric obesity. [PDF]
Wen H.
europepmc +1 more source

